Choline

Choline

SCHEMBL8994290

CCO.C[N+](C)(C)CCO

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3GNRHRMPLPDE3APDE3BPDE4APDE4BPDE4CPDE4DPPARASLC5A2

The experimentally established mechanism targets of Choline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.80
KMT2A Q03164 5/20 0.80
LMNA P02545 2/20 0.80
CYP3A4 P08684 1/20 0.80
SLC5A7 Q9GZV3 1/20 0.80
TSHR P16473 2/20 0.43
ALDH1A1 P00352 1/20 0.43
DNM1 Q05193 6/20 0.42
APEX1 P27695 3/20 0.39
NFKB1 P19838 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ACHE P22303 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
PMP22 Q01453 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Choline SCHEMBL8383204 0.97 MEN1 (0.75) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL27304568 0.97 CYP3A4 (0.87) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL27919600 0.94 MEN1 (0.71) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL21380518 0.93 MEN1 (0.80) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL300867 0.93 MEN1 (0.92) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL13169639 0.93
Choline SCHEMBL8012313 0.93 MEN1 (0.92) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL17629823 0.93 MEN1 (0.92) MEN1KMT2ALMNACYP3A4SLC5A7
Choline SCHEMBL16558587 0.93
Choline SCHEMBL29394392 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105085437-B Amphipathic derivatives of 3- (1- tert-butoxy carbonyl piperazines -4-yl) propionic acid and application thereof 上海交通大学 2018-07-03 CN claimed
CN-105085292-B Amphipathic derivatives of 3 ((2 (dimethylamino) ethyl group) (methyl) amino) propionic acid and application thereof 上海交通大学 2017-12-15 CN claimed
EP-2666773-B1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL CO LTD (CN) 2017-07-26 EP claimed
US-9233954-B2 Organic amine salts of Azilsartan, preparation method and use thereof JIANGSU HANSOH PHARMACEUTICAL CO., LTD. (CN) 2016-01-12 US claimed
EP-2666773-A1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF Jiangsu Hansoh Pharmaceutical Co., Ltd. (CN) 2013-11-27 EP claimed
US-20130296334-A1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL CO., LTD. (CN) 2013-11-07 US claimed
CN-114681395-A Galanthamine hydrobromide cream and preparation method thereof 鲁南制药集团股份有限公司 2022-07-01 CN disclosed
CN-111138263-B Method for separating phorbol alcohol by utilizing ultrasonic-assisted alcoholysis-extraction coupling technology 南昌大学 2021-07-20 CN disclosed
CN-111138263-A Method for separating phorbol alcohol by utilizing ultrasonic-assisted alcoholysis-extraction coupling technology 南昌大学 2020-05-12 CN disclosed
WO-2019188432-A1 RESIN COMPOSITION AND ELECTRONIC COMPONENT 日本ゼオン株式会社 2019-10-03 WO disclosed
CN-105085437-B Amphipathic derivatives of 3- (1- tert-butoxy carbonyl piperazines -4-yl) propionic acid and application thereof 上海交通大学 2018-07-03 CN disclosed
CN-105085292-B Amphipathic derivatives of 3 ((2 (dimethylamino) ethyl group) (methyl) amino) propionic acid and application thereof 上海交通大学 2017-12-15 CN disclosed
CN-107383336-A A kind of blood compatibility medical polyurethane material and preparation method thereof 成都优瑞商务服务有限公司 2017-11-24 CN disclosed
EP-2666773-B1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL CO LTD (CN) 2017-07-26 EP disclosed
US-9233954-B2 Organic amine salts of Azilsartan, preparation method and use thereof JIANGSU HANSOH PHARMACEUTICAL CO., LTD. (CN) 2016-01-12 US disclosed
EP-2666773-A1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF Jiangsu Hansoh Pharmaceutical Co., Ltd. (CN) 2013-11-27 EP disclosed
US-20130296334-A1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF JIANGSU HANSOH PHARMACEUTICAL CO., LTD. (CN) 2013-11-07 US disclosed
CN-1879788-A Virus-clearing capsule GOU CHUNHU (CN) 2006-12-20 CN disclosed
US-5567419-A IMPROVED STORAGE STABILITY AND ORGANOLEPTIC PROPERTIES KANEBO LTD. (JP) 1996-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130296334-A1 ORGANIC AMINE SALTS OF AZILSARTAN, PREPARATION METHOD AND USE THEREOF REN, AGTR2, AGTR1 MEN1 1091/4885KMT2A 767/4885LMNA 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.